Response after 12 weeks of ranibizumab therapy can predict long-term outcomes in diabetic macular edema, a post hoc analysis suggests. Medscape Medical News
Tag: News
First Response to Anti-VEGF Predicts Macular Edema Outcome
In branch retinal vein occlusion secondary to macular edema, assessment a month after the first anti-VEGF treatment predicts long-term outcome better than baseline testing, a case series shows. Medscape Medical News
Fewer Visits for Aflibercept Injection With Observe and Plan
For patients with neovascular age-related macular degeneration, ‘observe-and-plan’ leads to fewer visits for anti-VEGF injections and a more efficient use of clinic resources, 2-year data show. Medscape Medical News
Is Anti-VEGF Monotherapy Best for Diabetic Macular Edema?
One of the predictors of visual improvement in patients with diabetic macular edema is ranibizumab monotherapy, an analysis of the RESTORE data shows, but not everyone agrees with the findings. Medscape Medical News
Zika Virus Found in Tears of Mice – U.S. Study
A new study has found genetic fragments of Zika in the eyes and the tears of laboratory mice infected with the virus, a finding that offers a potential new route of human infection. Reuters Health Information
Artificial Vision, Anti-VEGFs Focus of EURETINA Congress
Artificial vision, anti-VEGF therapies, and interactive sessions with thought leaders discussing the latest studies are planned for the European Society of Retina Specialists 16th EURETINA Congress. Medscape Medical News
Laser, Manual Cataract Surgery Equivalent
Compared with manual surgery, the advantages and disadvantages of femtosecond laser-assisted cataract surgery may cancel each other out, a meta-analysis suggests. Medscape Medical News
Adalimumab Lowers Risk of Uveitic Flare
Adalimumab reduces the risk of uveitic flare after corticosteroid withdrawal in patients with inactive, noninfectious uveitis, according to results from VISUAL II. Reuters Health Information
Treat-and-Extend May Fall Short in Some Macular Degeneration
Lesions with a long initial induction to inactivity may be undertreated with anti-VEGF medication in a treat-and-extend protocol for neovascular age-related macular degeneration. Medscape Medical News
Blindness Due to Diabetic Retinopathy Surges Worldwide
The percentage of blindness and visual impairment attributable to diabetic retinopathy was lower in low-income regions with younger populations and higher in high-income parts of the world. Medscape Medical News
Contact Lens Complications Tied to Permanent Eye Damage
Nearly one in five contact-lens related eye infections reported to the US Food and Drug Administration results in damage to the eye, according to a new analysis. Medscape Medical News
Topical Antibiotics Unnecessary for Intravitreous Injections
Topical antibiotics are unnecessary in patients receiving intravitreous injections, but povidone-iodine is important for preventing endophthalmitis, according to results from the Diabetic Retinopathy Clinical Research Network. Reuters Health Information
Diabetic Retinopathy Risk Drops With Diet Rich in Marine PUFAs
At least two meals per week containing oily fish, rich in omega-3 fatty acids, seems enough to cut the risk by almost half in people with type 2 diabetes, suggests a post hoc analysis of a major trial. Medscape Medical News
Oops! Surgeons Need to Guard Tongue in ‘Awake’ Operations
Physicians create code words for mistakes and choose words carefully to avoid alarming patients during awake surgical procedures. Medscape Medical News
Vancomycin in Cataract Procedures May Cause Blindness
Researchers have documented 35 eyes with severe hemorrhagic occlusive retinal vasculitis after treatment with vancomycin during cataract procedures. Medscape Medical News
New Batches of Ranibizumab Biosimilar Safe, Effective
Razumab, an Indian biosimilar for ranibizumab, appears to have overcome the high incidence of inflammation with a new manufacturing process, report investigators. Medscape Medical News
Real-World Anti-VEGF Data Disappointing
Administered under real-life circumstances, anti-VEGF treatments produce much worse results than they do in clinical trials, according to an analysis of 750,000 patients in the US. Medscape Medical News
Genes May Shape Supplements’ Effect on Macular Degeneration
Two new studies have reignited the controversy over the relationship of genes to the AREDS formulation of supplements being marketed to slow macular degeneration. Medscape Medical News
Patients With Dry Eye and Normal Visual Acuity Read More Slowly
People with dry eye read more slowly, even if they have normal visual acuity, according to a new report. Reuters Health Information
Retina Treatment Adverse Events to Take Center Stage at ASRS
Investigators at the American Society of Retina Specialists annual meeting will explore the adverse effects of treatments for diabetic retinopathy, cataracts and macular degeneration. Medscape Medical News